PTHLH and non-small cell lung carcinoma: Another study demonstrated that the EGF receptor promotes PTHrP production, since treatment with erlotinib, an EGF receptor tyrosine kinase inhibitor, suppresses PTHrP expression in non-small cell lung cancer cells and reduces osteolysis (175).